logo

Otonomy Inc. (OTIC)



Trade OTIC now with
  Date
  Headline
8/30/2017 7:04:57 AM Otonomy Reports Results For Its AVERTS-1 Phase 3 Clinical Trial Of OTIVIDEX In Patients With Ménière’s Disease
8/30/2017 7:04:21 AM Otonomy Trading Halted; Expected To Resume At 7:30 AM ET
1/19/2017 7:35:08 AM Otonomy Initiates Patient Enrollment In Phase 2 Trial Of OTO-104 As Protectant Against Cisplatin-Induced Hearing Loss
1/5/2017 7:05:39 AM Otonomy Announces Positive Top-Line Results From Phase 3 Trial Of OTIPRIO® In Patients With Acute Otitis Externa
10/4/2016 7:36:37 AM Otonomy Completes Phase 2 Trial Of OTIPRIO In Pediatric Patients With Acute Otitis Media With Tympanostomy Tubes
9/15/2016 7:36:13 AM Otonomy Completes Open-Label Clinical Trial For OTIPRIO In Patients With History Of Otitis Media Requiring TTP